Literature DB >> 24659758

Seroconversion risk perception among jail populations: a call for gender-specific HIV prevention programming.

Leanne Fiftal Alarid1, Jeannie M Hahl.   

Abstract

The prevalence of HIV/AIDS infection among prisoners is 3 to 4 times higher than in the U.S. population. Given that one in seven HIV-positive Americans pass through a correctional facility every year, the criminal justice system is in an ideal position to aggressively implement effective HIV education, treatment, and prevention. This study examines barriers to the effective delivery of these services and evaluates differences in risk perception among nearly 600 female and male inmates. The results underscore gender differences in Perceived Risk of Seroconversion and Exposure to HIV Education, suggesting that jails should implement gender-specific HIV prevention programming.

Entities:  

Keywords:  HIV education; HIV prevention; HIV/AIDS; gender-specific; inmates

Mesh:

Year:  2014        PMID: 24659758     DOI: 10.1177/1078345813518631

Source DB:  PubMed          Journal:  J Correct Health Care        ISSN: 1078-3458


  3 in total

1.  Gender Differences in HIV Risk Behaviors Among Persons Involved in the U.S. Criminal Justice System and Living with HIV or at Risk for HIV: A "Seek, Test, Treat, and Retain" Harmonization Consortium.

Authors:  Kelsey B Loeliger; Mary L Biggs; Rebekah Young; David W Seal; Curt G Beckwith; Irene Kuo; Michael S Gordon; Frederick L Altice; Lawrence J Ouellet; William E Cunningham; Jeremy D Young; Sandra A Springer
Journal:  AIDS Behav       Date:  2017-10

2.  The HIV pre-exposure prophylaxis continuum of care among women who inject drugs: A systematic review.

Authors:  Danielle Guy; Jason Doran; Trenton M White; Lena van Selm; Teymur Noori; Jeffrey V Lazarus
Journal:  Front Psychiatry       Date:  2022-08-26       Impact factor: 5.435

3.  Perception of HIV/AIDS Education at the Community Level in Jordan.

Authors:  Fathieh Abu Moghli; Suhair Al Habeesh; Lubna Abu Shikha
Journal:  Iran J Public Health       Date:  2017-03       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.